In this paper the definition of neocortical TLE is based primarily on the electrophysiological criteria required to select the type of resection to be used and less so on a clearcut description of the clinical picture typical of neocortical TLE. Thus this paper does not represent a continuation of the clinical work of some authors 4, 7, 11, 16, 17, 28, 35, 43, 45, 46 who have tried to delineate clinical or other differences between mesial and neocortical TLE. In our epilepsy surgery center, for several years a well-differentiated resection strategy has been made possible by using a presurgical evaluation protocol aimed at differentiating among purely mesial, purely lateral, and combined mesiolateral origins of seizure. Over the years the standard two-third lateral lobectomy, which we initially used in treating all types of TLE, was changed to a more precise, or tailored approach. Anterior two-third lobectomy with amygdalohippocampectomy, mesial lesionectomy with amygdalohippocampectomy, selective amygdalohippocampectomy, or lateral lesionectomy with hippocampectomy is used to treat patients with mesial TLE; lateral lobe resections, lesionectomies, and lateral corticectomies are used to treat those with neocortical TLE. For the present series, however, all patients in whom the hippocampus was resected were excluded; therefore, the data presented in this paper reflect a well-defined series of neocortical TLE cases. These 62 cases were selected from a group of 581 TLE surgeries (Table 1) .
Clinical Material and Methods
Data obtained in 62 patients with drug-resistant neocortical TLE were included in this study. All patients fulfilled the following criteria: a minimum 1-year history of drug-resistant epilepsy; adequate trials of at least two firstline AEDs; and continuous noninvasive scalp video EEG monitoring, which was performed using sphenoidal electrodes. Data compiled for this study were obtained from three databases containing prospectively collected data on clinical features, presurgical evaluations, operative procedures, complications, histological findings, and follow-up information. Follow-up data were collected at 3-month intervals during the 1st postoperative year and annually during the ensuing years. Electrophysiological, outcome, and neuropathological data were reexamined and completed at the time this article was written.
As has been the case in previous studies, 51, 53 seizure outcome was classified according to the scale proposed by Engel, et al.: 9 Class I, free from seizure (auras possible); Class II, no more than two seizures per year; Class III, more than a 75% reduction in seizure frequency; and Class IV, less than a 75% reduction in seizure frequency. Withdrawal of AEDs is usually initiated in the Bonn epilepsy program after 2 continuous years of postoperative freedom from seizure.
Presurgical Evaluation and Indications
Although there are signs with respect to seizure symptomatology, as well as neuropsychological findings that are more often associated with either mesial or lateral zones of seizure onset, these symptoms and signs usually do not permit an unequivocal diagnosis of mesial or lateral TLE. For the purpose of the present study, we therefore adopted an operant definition of neocortical TLE. We chose the diagnosis of neocortical in contrast to mesial TLE when MR images revealed no signs of mesial temporal disease and seizure recordings clearly identified onset of seizure in the lateral temporal lobe. In neocortical TLE, proof of the latter event often required invasive recordings to be made using subdural strip electrodes. In all patients, the detailed clinical history of seizure symptomatology, together with previous EEG recordings and, in some patients, results from earlier MR imaging, were used to generate a preliminary hypothesis concerning the primary epileptogenic area. All patients received comprehensive neuropsychological testing of attention, memory, language, and higher verbal and visual reasoning. 19, 21 Multichannel long-term video EEG recording was performed to evaluate interictal focal activity as well as ictal EEG patterns and seizure symptomatology. Details on interpretation of presurgical EEG findings have been published previously. 23, 24, 51, 53 All patients underwent presurgical MR imaging and, if necessary, computerized tomography scanning. Our standard presurgical MR imaging protocol has been described previously. 34, 51, 53 Functional images obtained using positron emission tomography and/or single-photon emission computerized tomography scanning, as well as the results of intracarotid amobarbital testing of language and memory, 15, 27 were used as adjunct investigative tools when needed.
Invasive Recordings
The type of electrodes we used and the details of our evaluation protocol and implantation procedures have been published elsewhere. 3, 8, 10, 42 Invasive recordings were obtained in 26 (43%) of 61 patients (in 20 patients [33%] this included recordings from depth electrodes), leaving 35 patients (57%) in whom only noninvasive evaluation was performed. Intraoperative electrocorticography was never used in this series. Subdural strip and grid electrodes, as well as depth electrodes, were used either alone or in combination. 3, 10, 42 An invasive procedure was indicated when at least one of the following conditions was met: 1) inconclusive results of ictal, surface EEG recordings due to artifacts, recording of generalized or multifocal ictal EEG patterns in patients in whom there is a hypothesized monofocal epilepsy, absence of recognizable ictal EEG patterns, or ictal onset incongruent with the findings on MR images of seizure symptomatology; 2) no detectable lesion observed on a standard high-resolution MR image 34, 51, 53 in addition to findings from long-term monitoring that do not exclude extratemporal seizure onset; 3) suspicion of a bilateral or extratemporal origin of the seizure or of a major functional impairment of the contralateral temporal lobe because of the results of imaging, electrophysiological, and neuropsychological studies; and 4) necessity of electrical stimulation mapping through subdural grid electrodes because there is possible overlap between epileptogenic and temporal lobe language areas.
Planning for resection of the epileptogenic area was finally based on the comprehensive results of noninvasive and, if necessary, invasive procedures. In patients harboring a tumor or other lesion, occasional use of a combination of intrahippocampal depth electrodes and subdural electrodes was necessary to discriminate between hippocampal and perilesional seizure origin.
Surgical Method
Depth electrodes were inserted into the longitudinal axis of the hippocampus; sometimes they were accompanied by grid electrodes in cases of temporodorsal lesions. The details and complications of invasive recordings from this center have previously been described. 2, 3, 10, 42 The epilepsy surgery consisted of either resective surgery or MST (Table 1 ). All operations were performed while the patient was in a state of general anesthesia because mapping of language function is usually done extraoperatively. If a lesion was detectable on MR images, the aim of surgery was complete removal of the lesion and the ictal zone, unless the region of ictal onset overlapped eloquent areas. In that case, MST was performed alone (one patient) or in addition to resective procedures (two patients). A lesionectomy was accompanied in the majority of cases by a corticectomy of the surrounding cortex (that is, lesionectomy with a rim) extending to a minimum of at least 0.5 and a maximum of 1 cm). The extent of the surrounding corticectomy of the epileptogenic zone was guided by the results of earlier recordings obtained from the implanted strip or grid electrodes. Because intraoperative electrocorticography was never used in this series to guide the surgeon, the results obtained from the presurgically implanted strips and grids obviously had to have been sufficiently clear. Lateral corticectomies were performed much more frequently than lateral lobe resections. During lesionectomies (with or without surrounding corticectomy) and corticectomies, the two layers of arachnoid defining the sulci were usually left intact, including the vessels lying between them. In particular, larger arteries were spared and isolated. The conventional sucker of an ultrasound aspirator with both suction and vibration turned to very low levels is a quite adequate instrument for this purpose. Bipolar coagulation is usually avoided and nearly all hemostasis can be achieved with application of pure Surgicel.
In lateral lobectomy-similar to a classic complete anterior lobectomy-the resection line extended 4.5 to 5.5 cm from the superior to the inferior temporal gyrus in the nondominant hemisphere and 4.5 cm in the dominant hemisphere. The amygdala, hippocampus, and parahippocampal gyrus were left behind. In the three patients who underwent MST, Wyler's modification was used. 49 Fisher's exact test was used for group comparisons with ␣ set at 0.05. Usually, combined outcome Classes I and II were compared with combined Classes III and IV (worthwhile improvement compared with unsatisfactory outcome).
Neuropathological Evaluation of Surgical Specimens
A standardized neuropathological examination protocol has been used for many years in patients undergoing epilepsy surgery, and all relevant data are prospectively collected in a databank. 48, 53 Histological evaluation was possible in 61 cases in our series; no histological evidence was available in the case in which an MST was performed. Surgical specimens were fixed in 4% formalin and embedded in paraffin. Four-micrometer-thick sections were evaluated microscopically for the presence of histopathological lesions. Tissue reactions to hematoxylin and eosin, Nissl, and combined hematoxylin and eosinLuxol fast blue stains were analyzed as well as immunohistochemical reactions for glial fibrillary acidic protein, synaptophysin, neurofilament protein, and Ki-67. All specimens were independently examined by two neuropathologists and classified with respect to the presence of a neoplastic lesion or a malformation. Neuropathological evaluation of neoplastic lesions was performed according to the World Health Organization classification.
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Results
Clinical Data
Patients with neocortical TLE accounted for 10.7% of all patients with TLE who were treated during the same period (Table 1) . Circumscribed corticectomies or lesionectomies were more commonly performed anteriorly than dorsally, with the latter being as common as anterior twothird lateral lobectomies. Multiple subpial transections were performed in three patients, twice as adjuncts to resection. Three patients (4.9%) experienced complications, two of which were surgical (meningitis) and one neurological (dysphasia). There was no permanent incidence of morbidity or mortality.
There were 34 female and 27 male patients in this series who underwent resective surgery. The mean followup period in this group was 21.9 Ϯ 14 months (range 1-71 months). The median length of follow up was 24 months. At least 2 years of follow-up data were available in 32 patients, 81% of whom became seizure free. Freedom from seizures was observed in 81% of the 36 patients in whom follow up exceeded 1 year, 88% of 16 patients in whom it exceeded 2 years, 89% of nine patients with more than 3 years, 80% of five patients with more than 4 years, and one patient in whom the follow-up period was longer than 5 years. At the time this paper was written, AED treatment had been discontinued in 11 patients and withdrawal of AEDs had been initiated in seven. One patient experienced recurrence of auras after AED withdrawal. Reintroduction of carbamazepine in monotherapy resulted in renewed control of all seizures including auras. Reduction in AED dosage had not yet been initiated in seven patients undergoing antiepileptic monotherapy (six of whom had been receiving carbamazepine and one valproate), in most cases because of the patient's special request. One additional patient underwent MST alone. Because the region of interest was an eloquent area of the brain, no resection was performed in this case and no histological specimen was obtained. For this reason many correlations with other cases cannot meaningfully be made, and we must describe this case separately. The patient was 19 years old at seizure onset and 39 years old at operation. He experienced no auras, but suffered from CPSs and, sometimes, secondary GMSs. He underwent evaluation performed using a grid implantation. Follow up lasted for 7 months in this case and the patient's seizure outcome was Engel Class II.
The age of the patients at seizure onset and at operation, and the duration of the seizure disorder for all patients who underwent resection and for the five histological subgroups are shown in Table 2 . There are nonsignificant differences in the mean patient age at operation and the duration of seizure disorder. The mean age of patients at seizure onset was very similar for the neoplastic lesion, gliosis, and dysplasia groups, but was higher for the vascular malformation group. The mean duration of seizure disorder in patients with neoplastic lesions was high-14 years.
Thirty-four of 61 patients reported having auras and 27 did not report having auras. Five types of seizure were seen, either alone or in various combinations. The most common were CPSs, followed by a combination of CPS and secondary GMSs (Table 3) . Simple partial seizures were the third most frequently occurring seizures. More than one seizure type or combination was possible in the same patient. No difference in seizure type was detectable between patients with neoplastic lesions and those without them. Only rarely did we find absence of seizures; tonic, clonic, or tonic-clonic seizures; or a combination of SPSs and GMSs.
Histopathological Findings
Neuropathological diagnoses were divided into three groups: no detectable neuropathological lesion (nonlesional cases), neoplastic lesions, and nonneoplastic lesions (Table 4 ). In only three of the 61 cases in which histological findings were obtained were there no lesions. (In one patient no histological specimen was obtained because MST alone was performed in a highly eloquent area.) Tumors were present in 57% of the patients for whom we had histopathological findings, nonneoplastic lesions were present in 38%, and no lesion was present in 5%. Among the nonneoplastic lesions, cavernous malformations were the most frequently observed. There were no arteriovenous malformations and, among the patients with gliosis three of five lesions had developed as a sequela to another lesion in the brain. In seven (30%) of the 23 patients harboring nonneoplastic lesions, cortical dysplasias (or malformed lesions) were identified in temporal lobe specimens. In four of these patients these lesions were determined to be glioneuronal hamartomas. These paucicellular mass lesions consist of disorganized, but mature neuronal cell elements placed within an astroglial matrix. Mitotic figures or Ki-67 proliferation activity were not detectable. These lesions predominantly occur within the neocortex, but also involve adjacent white matter. In two patients abundant neurons were found in white matter. This category is based on the identification of more than 10 neurons per high-power field, according to Kasper, et al., 25 and Rojiani and associates. 37 In one patient, nodular cortical heterotopia was identified. The histological specimen in this case demonstrated multiple gray matter islands surrounded by myelinated white matter tracts. All nodules and also adjacent neocortex were found to possess abnormal cytoarchitectural organization.
Patients with neoplastic lesions formed the largest group, with 57% of the histopathological diagnoses. The vast majority of these tumors were low-grade tumors with only one of 35 tumors classified as a higher grade. Sixty percent of the lesions were classic long-term epilepsy-associated tumors, namely gangliogliomas (18 cases) and dysembryoplastic neuroepithelial tumors (three cases). Variants of so-called normal gliomas were less frequently found (40% of cases) than the typical long-term epilepsy-associated tumors. It is remarkable that one third of the tumors belonged to either ordinary astrocytoma or oligodendrocyctic tumor types, which are usually found in patients with tumor in whom there is only a brief history of epilepsy and in whom survival time is expected to be shorter than the duration of the seizure disorder. One highgrade tumor appeared to have developed from an undifferentiated low-grade tumor. In one patient with a malignant brain tumor, the patient's age at onset of the seizure disorder was 16 years and the age at operation was 24 years, after an 8-year history of the disorder. Because the average length of survival in patients with low-grade astrocytomas is approximately 5 to 7 years, it is very likely that the high-grade tumor developed from a longstanding lowgrade tumor and, thus, this case does not represent a primary high-grade glial tumor that inadvertently slipped into this epilepsy surgery series. Table 5 provides a list of seizure outcomes for the group of patients as a whole and for various subgroups. Of all patients with neocortical TLE, a worthwhile improvement in their seizure status was achieved in 90%, with Class I outcomes in 79% and Class II outcomes in 11%. 9 In an examination of subgroups, a difference between patients with neoplastic and nonneoplastic lesions is evident; however, this difference is not statistically significant if outcome Classes I and II are combined and tested against combined outcome Classes III and IV by using Fisher's exact test (␣ = 0.05). If outcomes in patients with nonneoplastic lesions are broken down, some differences can be observed among dysgenesis, vascular malformation, and gliosis cases, but these differences are insignificant.
Seizure Outcomes
Surprisingly, of the three cases in which no histopathological abnormality was found, two patients became seizure free postoperatively. The worthwhile improvement (combined outcome Classes I and II) rate of 90% for the patients with neoplastic lesions is surprisingly high.
In addition to histological findings, a number of other variables that might influence outcome were examined (Table 5) . Patients who did not undergo invasive evaluation (35 cases) fared much better than those who did (26 cases) , and this will be discussed later in this paper. The presence or absence of an aura did not significantly correlate with outcomes for epilepsy surgery. If resection type is compared with outcome classes, two facts become evident. First, the surgical distinction between an anterior corticectomy or lesionectomy alone, on the one hand, and a temporodorsal corticectomy-lesionectomy, on the other hand, is not justified by a difference in outcome data. Second, patients in whom an anterior two-third lateral lobectomy was performed fared somewhat better compared with those in whom a lesionectomy or corticectomy was performed, although this difference was not statistically significant. The side on which the operation was performed did not affect outcome (Table 5 ). Table 6 shows patient ages at seizure onset and at surgery and the duration of seizures for the various outcome classes. The duration of the seizure disorder varied little among outcome classes except for Class III; this is probably because of the small number of patients in that outcome class. In summary, it appears that for this group the age at seizure onset and the duration of seizures do not influence outcome. If patient age at surgery is considered alone (Table 7) , grouping outcome Classes I and II together as worthwhile improvement and comparing them with Classes III and IV combined as nonsatisfactory improvement yields no sig-
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Discussion
Definition, Presurgical Diagnosis, and Demographics
It has been only a few years since neocortical TLE was first viewed as a separate electroclinical syndrome, 41, 45, 46 and only a few clinical papers dedicated to this topic have been published. 4 It has been mentioned that a purely anatomical distinction between neocortical and mesial TLE is unlikely to be adequate 45 and, in fact, Wieser and colleagues 46 have pointed out that, in contrast to mesial TLE, in neocortical TLE there are ". . . lesions outside the limbic system with ictal discharges that rapidly propagate into the limbic system. . . ." This definition certainly implies that lesions or a morphologically innocent ictogenic zone in the neocortex of the temporal lobe may also have been included. Although Wieser and colleagues 46 have differentiated five electroclinical seizure types in TLE, Walczak 45 has pointed out that comparatively little information about neocortical TLE is available and that distinctive characteristics are lacking. Pacia, et al., 35 have also stated that the clinical features of neocortical TLE remain poorly defined. Foldvary and colleagues 11 found that the presence of a particular variable may be a good predictor for mesial TLE, but the absence of mesial TLE predictors per se is no evidence to support a diagnosis of neocortical TLE. During presurgical evaluation of TLE, arriving at the precise definition of neocortical, as opposed to mesial or limbic, TLE may be further complicated by the presence of dual pathological conditions, as pointed out by Lévesque, et al., 28 and Cascino and associates. 5 Even leaving aside the problem of dual pathological conditions, although they might be detected during presurgical MR imaging evaluation, the presence of a single lesion does not reliably point to the zone of seizure onset. This was stressed in a study by Holmes and coworkers, 22 who, in a series of 20 patients in whom MR imaging studies revealed lesions only in the hippocampus or only in the neocortex, found that the site of seizure onset could be completely different from the site of the lesion.
The process of differentiating lateral from mesial TLEs occurs in several steps. First, the semantic differentiation has to be made; second, different electrophysiological pictures have to be described, usually based on appropriate MR imaging findings; and third, possible distinct features of the two clinical syndromes can be worked out. Because the primary seizure type is complex partial in both mesial and lateral TLEs, determination of the main differences between them could be expected to be based on electrophysiology, initial seizure symptomatology, and, possibly, neuropsychological deficits. The definition of specific lateral neocortical syndromes would certainly profit from a comparison of patients whose neocortical or mesial TLE was fully treated. This has been done using positron emission tomography scanning 4, 16 and MR imaging, 22 examining clinical and EEG signs, 32 and comparing neuropsychological defects. An in-depth presentation of the neuropsychological data obtained in these patients would be beyond the scope of this paper. Two studies in which neuropsychological outcomes following lateral and mesial resections were compared have indicated less postoperative impairment, in both verbal and visual memory, in right-and left-sided TLE cases treated by lateral resection. 14, 20 Fried and Spencer 13 summarized two possible ways to work up suspected neocortical TLE cases: using either a systematic classification according to the five types defined by Wieser, et al., 46 or making an individual decision based on the results of intra-or extraoperative ictal and interictal discharge mapping.
The mean patient age at seizure onset, 14.4 years, did not differ much from the 15.9 years found in our previous TLE series. 53 The same is true for the mean patient age at operation which was virtually identical in both series. The duration of the seizure disorder in cases of neocortical TLE-a mean of 13.6 years-was also not significantly different from the 15.9 years found in our earlier TLE series, with the exception of the vascular malformation subgroup, in which patients were slightly older at seizure onset (mean 19.2 years). This time does not necessarily reflect delayed diagnosis but delayed referral. The responsibility for the delay lies outside the neurosurgeon's influence; it may reflect a conservative attitude on the part of practicing neurologists against aggressively investigating chronic epilepsy cases for the possibility of epilepsy surgery.
The mean patient ages at seizure onset for neoplastic and nonneoplastic groups in this series were nearly identical to those in our previous TLE series. 53 It might therefore be concluded that, although neocortical TLE is more poorly defined and, possibly, more difficult to diagnose, there appears to be no obvious prolongation in the duration of the seizure disorder compared with an average TLE group (that is, patients in whom resection of mesial structures is indicated). In our earlier study, patients with Ammon horn sclerosis were older than patients in other subgroups, and in the neocortical TLE group patients with cavernous malformations were older than the other patients at the start of the seizure disorder. The mean patient age at seizure onset in the group investigated by Pacia, et al., 35 was also very similar to the mean age of our group.
Surgical Aspects
For this study we included only patients who underwent a purely lateral neocortical resection that did not extend into the parahippocampal gyrus. Thus, all cases were excluded in which synchronous neocortical and limbic seizure origins were observed or slightly delayed or inconsistent synchronous mesial seizure origin was seen in addition to lateral seizure origin. If a clear-cut lesion-plusictal-onset zone is well defined laterally and a relevant secondary ictal onset zone is defined mesially, a recommendation for lesionectomy plus hippocampectomy is usually made. Only if EEG findings are variable, inconsistent, or relevant to both lateral and mesial structures is a recommendation for temporal lobectomy still made.
By only including purely lateral resection types and excluding neocortical TLE cases from the earlier period of our TLE series, during which these cases were treated using classic anterior two-third lateral lobectomy, we avoided all ambiguity about the issue of a significant mesial contribution to seizure onset or the significance of dual pathological conditions, which has been discussed by several authors. 5, 12, 28, 45 Thus, the TLE cases treated during the first few years of the Bonn epilepsy series were not screened for possible neocortical TLE cases, because we did not want to include patients who, at another time with a different MR imaging standard, had been classified as best candidates for temporal lobe resections that included mesial structures. We considered this to be better, because, after resection of mesial structures in those neocortical TLE cases, any results pertaining to freedom from seizures would have been taken from a mixed group of cases surgically treated with and without hippocampal removal, although the electroclinical syndrome would have been classified as lateral neocortical only.
The growing experience with neocortical TLE and the tendency to develop better differentiated suggestions for resection in the Bonn series has also been pointed out by Olivier 33 and by Fried and Spencer. 13 The latter authors also assert that future studies will have to address longterm outcomes of variants of temporal lobe resections. The duration of follow up in these series is just under 2 years and does not allow for a comparison of long-term outcome, which would be of interest regarding the differences between lateral neocortical TLE lobe resection and lesionectomies or corticectomies (Table 5) .
This development has evolved slowly 20, 53 and, obviously, in a similar fashion in other centers. 12, 33 The suggestion made by Wieser and colleagues 46 that the five psychomotor seizure types they described for TLE should be treated by different resections has begun to be followed. Helmstaedter, et al., 20 reviewed three groups of patients: one treated with lobectomy, one with neocortical resection only, and one with selective amygdalohippocampectomy only. They found that patients who underwent selective amygdalohippocampectomy and those who underwent lobectomy had very similar increases in neuropsychological deficits in long-term memory after surgery and that patients who underwent selective amygdalohippocampectomy fared significantly better in the immediate-recall category. Patients who underwent neocortical resections, however, fared best according to the neuropsychological memory findings, and seizure outcome did not account for these results. Cascino, et al., 5 reviewed a number of cases in which mesial and lateral morphological findings were present simultaneously and concluded that, instead of recommending lateral lesionectomy, they now opt for lobectomy instead.
Seizure Outcomes
Worthwhile improvement was achieved in 90% of cases in this series, with 79% of patients being seizure free. These results compare well with those obtained for TLE in general. 9, 33, 36, 53 Hajek and associates 16 and Fried and Spencer, et al., 13 discussed presumably less favorable outcomes in patients with neocortical TLE. The present study with a 79% rate of freedom from seizures (and two others with 72% and 60% rates of freedom from seizures 4, 32 ) does not differ much in its results from those achieved in classic surgery for TLE. In summary, we can confirm the findings of Burgerman, et al., 4 that there is no difference in outcome between patients with lateral and mesiobasal seizure onset. 4 The results of this series are basically the same as those of lesional cases because in only three of our cases were pathological findings nondiagnostic. "Nonlesional" for the purpose of this discussion is understood to mean nonlesional after neuropathological examination and not only after an MR imaging examination. In the series of Pacia, et al., 35 15 of 21 cases appeared nonlesional on MR images, but 63% displayed gliosis and 21% dysgenesis or migration disorders during the neuropathological examination, in addition to the other six cases in which there were obvious lesions such as hippocampus atrophy or tumors. Although Fried and Spencer 13 suggested that nonlesional neocortical TLE cases present the most difficult challenge, Burgerman, et al., 4 concluded that the resection results in nonlesional cases may be comparable to other cases. Our small proportion of three nonlesional cases does not allow us to draw firm conclusions; however, outcomes in two of the three cases were seizure free.
Outcome may adversely be affected in patients with concomitant hippocampal histological changes, 5, 16, 28 although such cases would have remained unidentified in this series. Hardiman and colleagues 18 have discussed outcome in a series restricted to lateral resections. Applying Crandall's outcome criteria, these researchers described a 52% rate of good outcome in a series of patients without demonstrable mass lesions and significant improvement in 88% of these patients. This rate is comparable to our dysgenesis subgroup as well as to the gliosis and nonlesion subgroups, in which a significant improvement (Classes I and II combined) could be achieved in 67 to 80% of the cases. Because vascular malformations and tumors were excluded from their study, their results can be compared with those of our nonneoplastic lesion subgroup minus the vascular cases, and we would have an equally high number of cases with different types of dysgenesis. In the series of Pacia, et al., 35 in which the epileptogenic area was nonlesional on MR images, gliosis and dysgenesis were frequently histological findings. The presence of a lesion was associated with significantly better outcome for the combined outcome Classes I and II compared with that for the combined Classes III and IV in the present series. This has also been observed in patients who have undergone surgery for tumors associated with longterm epilepsy 12, 52 and in TLE series in general. 53 Lesions in this context are defined as MR imaging-detectable lesions such as low-grade tumors, vascular malformations, or postlesional gross gliosis, as opposed to focal cortical dysplasia or microdysgenesis only recognizable with the aid of a microscope.
The fact that patients who did not undergo invasive evaluation experienced better outcomes must be carefully interpreted. Patients in whom invasive evaluation is indicated because of nonequivocal noninvasive findings appear to have a higher chance of experiencing an unsatisfactory outcome. Even the application of an invasive evaluation does not bring outcome figures up to the same level that was achieved in cases with clearer diagnoses in which invasive evaluation was not needed.
The influence of resection type on outcome (Table 5 ) should be judged carefully because the number in the lateral lobectomy group was small. There were no figures that could be pulled from the literature concerning similar resection types and similar histological groups.
The mean patient age at surgery and the mean duration of seizures in the four outcome classes can only be discussed reluctantly because the group size in outcome Class III is too small. Meaningful statistics are not possible; however, it appears unlikely that outcome is dependent on the duration of the seizure disorder or dependent on the patient age at surgery.
Neuropathological Findings
Neuropathological examination of surgical specimens obtained from TLE patients usually reveals a broad spectrum of underlying pathological conditions such as neoplasms, vascular malformations, or focal cortical dysplasia (alternatively named glioneuronal malformations). 18, 25, 32, 44, 48 The entire range of glioneuronal malformations, however, has yet to be unified into a comprehensive terminology, because a variety of different terms has emerged from the literature: "mild cortical dysplasia," 31 "focal cortical dysplasia," 40 "mild neuronoglial heterotopia," 44 and "microdysgenesis." 18, 30, 39 The term "focal cortical dysplasia" appears adequate to use as a common denominator for these changes. To differentiate morphologically distinct entities further, we used the term "glioneuronal hamartoma" for lesions characterized by disorganized but mature neuronal and glial cells indigenous to the particular site. 48 In our opinion, this term clearly indicates a developmental flaw, specifies the cellular elements involved, is not limited to a lesion of the cortex, and does not connote a preneoplastic disease. Despite its tumorlike gross appearance, a glioneuronal hamartoma displays no evidence of cellular growth and proliferation. These lesions have already been detected by MR imaging studies. In contrast to glioneuronal hamartoma, less circumscribed malformations that do not produce grossly visible masses on MR images can also be frequently encountered in TLE specimens. These lesions may relate to the term "microdysgenesis," including abundant neurons in the white matter, 29 increased densities of neurons in the neocortical molecular layer, 30 or perivascular clustering of oligodendroglia. 25 Small foci of glioneuronal hamartias composed of oligodendroglia-like clear cells and immature neurons 47, 50 were not encountered in our series of neocortical TLE specimens.
Conclusions
Our results confirm the notion that lateral or neocortical TLE is a definable entity separate from mesial TLE. Cases of neocortical TLE constitute a small subgroup of all TLE surgeries. In nearly all patients a lesion was demonstrated on MR images. Outcomes were slightly different depending on resection type. The most common lesions were low-grade tumors, which were found in more than half of all cases, with gangliogliomas representing half of all tumors. Nearly 40% of the tumors belonged to the astrocytic lineage most frequently found in patients with tumors who are not suffering from long-term epilepsy. Overall outcomes in these cases were worthwhile, with 90% of patients achieving Class I or II outcomes and 79% being seizure free. In this series there were no permanent neurological complications and no deaths. The necessity of an invasive evaluation appears to be a negative predictor of good outcome. Outcome was influenced by the type of lesion and less so by the type of resection. Outcomes in this group of patients with neocortical TLE were found to be as good as those in patients with mesial TLE. Surgery can thus be considered a viable and safe treatment option for patients with neocortical TLE, with a good chance of significant rates of seizure freedom and seizure reduction.
